4.7 Article

Early Identification of Patients at Risk of Acute Lung Injury Evaluation of Lung Injury Prediction Score in a Multicenter Cohort Study

Journal

Publisher

AMER THORACIC SOC
DOI: 10.1164/rccm.201004-0549OC

Keywords

respiratory distress syndrome; adult; prevention; prediction model; acute respiratory failure

Funding

  1. National Institute of Health [HL78743-01A1, 1 KL2 RR024151]
  2. Mayo Clinic Critical Care Research Committee
  3. Sanofi-Aventis
  4. Bristol Myer Squib/Pfizer
  5. University Of Missouri
  6. Vital Therapies
  7. Maquet, Inc.
  8. Eli Lilly
  9. Artisan Pharma
  10. Walker
  11. Allen
  12. Grice
  13. Ammons
  14. NIH
  15. American Lung Association
  16. American College of Surgeons
  17. Vapotherm in industry

Ask authors/readers for more resources

Rationale: Accurate, early identification of patients at risk for developing acute lung injury (ALI) provides the opportunity to test and implement secondary prevention strategies. Objectives: To determine the frequency and outcome of ALI development in patients at risk and validate a lung injury prediction score (LIPS). Methods: In this prospective multicenter observational cohort study, predisposing conditions and risk modifiers predictive of ALI development were identified from routine clinical data available during initial evaluation. The discrimination of the model was assessed with area under receiver operating curve (AUC). The risk of death from ALI was determined after adjustment for severity of illness and predisposing conditions. Measurements and Main Results: Twenty-two hospitals enrolled 5,584 patients at risk All developed a median of 2 (interquartile range 1-4) days after initial evaluation in 377 (6.8%; 148 ALI-only, 229 adult respiratory distress syndrome) patients. The frequency of ALI varied according to predisposing conditions (from 3% in pancreatitis to 26% after smoke inhalation). LIPS discriminated patients who developed ALI from those who did not with an AUC of 0.80(95% confidence interval, 0.78-0.82). When adjusted for severity of illness and predisposing conditions, development of ALI increased the risk of in-hospital death (odds ratio, 4.1; 95% confidence interval, 2.9-5.7). Conclusions: ALI occurrence varies according to predisposing conditions and carries an independently poor prognosis. Using routinely available clinical data, LIPS identifies patients at high risk for ALI early in the course of their illness. This model will alert clinicians about the risk of ALI and facilitate testing and implementation of ALI prevention strategies. Clinical trial registered with www.clinicaltrials.gov (NCT00889772).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available